DK0769054T3 - Immunmodulatorer - Google Patents

Immunmodulatorer

Info

Publication number
DK0769054T3
DK0769054T3 DK95920796T DK95920796T DK0769054T3 DK 0769054 T3 DK0769054 T3 DK 0769054T3 DK 95920796 T DK95920796 T DK 95920796T DK 95920796 T DK95920796 T DK 95920796T DK 0769054 T3 DK0769054 T3 DK 0769054T3
Authority
DK
Denmark
Prior art keywords
immunomodulators
Prior art date
Application number
DK95920796T
Other languages
Danish (da)
English (en)
Inventor
Borbala Gesser
Larsen Christian Groenhoej
Original Assignee
Steeno Res Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steeno Res Group As filed Critical Steeno Res Group As
Application granted granted Critical
Publication of DK0769054T3 publication Critical patent/DK0769054T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5428IL-10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95920796T 1994-07-05 1995-06-07 Immunmodulatorer DK0769054T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK80094 1994-07-05
PCT/DK1995/000227 WO1996001318A1 (en) 1994-07-05 1995-06-07 Immunomodulators

Publications (1)

Publication Number Publication Date
DK0769054T3 true DK0769054T3 (da) 2000-11-13

Family

ID=8097707

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920796T DK0769054T3 (da) 1994-07-05 1995-06-07 Immunmodulatorer

Country Status (28)

Country Link
US (3) US6159937A (ru)
EP (2) EP0769054B1 (ru)
JP (1) JPH10502249A (ru)
CN (1) CN1216992C (ru)
AP (1) AP690A (ru)
AT (1) ATE195003T1 (ru)
AU (1) AU686816B2 (ru)
BR (1) BR9508243A (ru)
CA (1) CA2194444C (ru)
CZ (1) CZ1497A3 (ru)
DE (1) DE69518156T2 (ru)
DK (1) DK0769054T3 (ru)
EE (1) EE03451B1 (ru)
ES (1) ES2148525T3 (ru)
FI (1) FI970009A (ru)
GR (1) GR3034628T3 (ru)
HK (1) HK1012416A1 (ru)
HU (1) HU220344B (ru)
MX (1) MX9606537A (ru)
NO (1) NO970020L (ru)
NZ (1) NZ287406A (ru)
PL (1) PL181042B1 (ru)
PT (1) PT769054E (ru)
RO (1) RO118758B1 (ru)
RU (1) RU2218348C2 (ru)
SK (1) SK283096B6 (ru)
UA (1) UA57702C2 (ru)
WO (1) WO1996001318A1 (ru)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
EP0906117A1 (en) * 1996-05-02 1999-04-07 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6086868A (en) * 1997-04-30 2000-07-11 Schering Corporation Method for treating or preventing ischemia-reperfusion injury
CA2316296A1 (en) * 1997-10-10 1999-04-22 Imperial College Of Science, Technology And Medicine Use of csaidtm compounds for the management of uterine contractions
EP1140142A2 (en) * 1998-12-22 2001-10-10 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
CA2373588A1 (en) * 1999-05-25 2000-11-30 Canji, Inc. Gene therapy of pulmonary disease
EP1404359A2 (en) * 2000-12-07 2004-04-07 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
US20040086896A1 (en) * 2001-04-19 2004-05-06 Julie Carman Polynucleotides and polypeptides associated with the NF-kB pathway
WO2003068152A2 (en) * 2002-02-11 2003-08-21 Arkion Life Sciences Llc Purified cytokine inhibitory factor
CA2477780A1 (en) * 2002-03-05 2003-09-18 Board Of Regents, The University Of Texas System Methods of enhancing immune induction involving mda-7
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
EP2266606B1 (en) * 2003-05-15 2014-09-10 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
US20050164244A1 (en) * 2003-10-23 2005-07-28 David Glass Methods of determining juvenile arthritis classification
CA2548220A1 (en) * 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
WO2005087793A2 (en) 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US20070281041A1 (en) * 2004-03-02 2007-12-06 Introgen Therapeutics, Inc. Compositions and Methods Involving MDA-7 for the Treatment of Cancer
WO2006063028A2 (en) * 2004-12-07 2006-06-15 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
KR101379364B1 (ko) * 2005-02-08 2014-03-31 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 암 치료를 위한 mda-7을 포함하는 조성물
WO2006119170A2 (en) * 2005-05-02 2006-11-09 Avigen, Inc. Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
EP2816118B1 (en) 2005-05-31 2018-10-17 The Regents of the University of Colorado, a body corporate Methods for delivering genes
RU2009101783A (ru) * 2006-06-21 2010-07-27 Апогеникс Гмбх (De) Дифференциальная экспрессия цитокинов il-4 и/или il-10 в злокачественной опухоли человека
EP2049147A2 (en) * 2006-07-06 2009-04-22 Apogenix GmbH Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
USRE46425E1 (en) 2006-12-13 2017-06-06 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
US7838497B2 (en) * 2006-12-13 2010-11-23 Susavion Biosciences, Inc. Pro-angiogenic peptides
US8460697B2 (en) * 2006-12-13 2013-06-11 Susavion Biosciences, Inc. Pro-angiogenic peptides and uses thereof
CN101391103B (zh) * 2008-07-31 2013-07-24 张可 一种预防和治疗艾滋病病毒感染的药物组合物
WO2010022227A1 (en) * 2008-08-20 2010-02-25 Schering Corporation Methods for monitoring il-10 therapy
WO2011047097A2 (en) 2009-10-13 2011-04-21 Sigalov Alexander B Inhibition of trem receptor signaling with peptide variants
RU2013145283A (ru) * 2011-03-14 2015-04-20 Флого АпС Новые антагонисты рецептора интерлейкина-1
US10167335B2 (en) 2012-02-13 2019-01-01 Agency For Science, Technology And Research IL-1β neutralizing human monoclonal antibodies
HUE046944T2 (hu) 2013-07-18 2020-03-30 Xalud Therapeutics Inc Készítmény gyulladásos ízületi betegség kezelésére
JP6140566B2 (ja) * 2013-07-31 2017-05-31 アイシン・エィ・ダブリュ株式会社 コイル装着方法及びコイル装着治具
CN105944086B (zh) * 2016-06-13 2017-08-25 浙江生创精准医疗科技有限公司 Il‑8单独或与其他细胞因子联合在治疗肝纤维化中的用途
US20180206726A1 (en) 2016-12-07 2018-07-26 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
US11596670B2 (en) 2017-03-30 2023-03-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist
WO2020106754A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
WO2020158858A1 (ja) * 2019-01-31 2020-08-06 積水メディカル株式会社 生物学的試料中の遊離aimの免疫学的分析方法及び対象におけるnashの検出方法
WO2021119482A1 (en) 2019-12-13 2021-06-17 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
ATE187336T1 (de) * 1991-08-06 1999-12-15 Schering Corp Verwendung von interleukin-10 analogen oder antagonisten zur behandlung von endotoxin- oder superantigen induzierter toxizität
ZA931489B (en) * 1992-03-04 1993-10-28 Schering Corp Use of interleuken-10 to suppress graft-vs-host disease
CA2085291A1 (en) * 1992-07-30 1994-01-31 Martin L. Breitman Novel receptor tyrosine kinase
HU220103B (hu) * 1992-08-20 2001-10-28 Schering-Plough Corp. IL-10 új alkalmazása
WO1995003411A1 (en) * 1993-07-26 1995-02-02 Schering Corporation Agonists and antagonists of human interleukin-10

Also Published As

Publication number Publication date
GR3034628T3 (en) 2001-01-31
AP9700962A0 (en) 1997-04-30
US6168791B1 (en) 2001-01-02
PL319429A1 (en) 1997-08-04
EP0769054B1 (en) 2000-07-26
AP690A (en) 1998-10-16
HU9603615D0 (en) 1997-02-28
RO118758B1 (ro) 2003-10-30
MX9606537A (es) 1997-12-31
HU220344B (hu) 2001-12-28
EP1013764A1 (en) 2000-06-28
CA2194444C (en) 2003-01-14
SK283096B6 (sk) 2003-02-04
CA2194444A1 (en) 1996-01-18
AU686816B2 (en) 1998-02-12
AU2612195A (en) 1996-01-25
EP0769054A1 (en) 1997-04-23
EE03451B1 (et) 2001-06-15
JPH10502249A (ja) 1998-03-03
UA57702C2 (ru) 2003-07-15
CN1159830A (zh) 1997-09-17
US6599501B1 (en) 2003-07-29
HK1012416A1 (en) 1999-07-30
ES2148525T3 (es) 2000-10-16
PL181042B1 (pl) 2001-05-31
EE9700029A (et) 1997-08-15
ATE195003T1 (de) 2000-08-15
DE69518156T2 (de) 2001-01-11
CN1216992C (zh) 2005-08-31
FI970009A (fi) 1997-03-04
PT769054E (pt) 2000-11-30
HUT76673A (en) 1997-10-28
SK161496A3 (en) 1997-08-06
RU2218348C2 (ru) 2003-12-10
US6159937A (en) 2000-12-12
NZ287406A (en) 1998-07-28
BR9508243A (pt) 1997-10-21
WO1996001318A1 (en) 1996-01-18
NO970020D0 (no) 1997-01-03
DE69518156D1 (de) 2000-08-31
NO970020L (no) 1997-03-05
CZ1497A3 (en) 1997-05-14
FI970009A0 (fi) 1997-01-02

Similar Documents

Publication Publication Date Title
DE69518156T2 (de) Immunomodulatoren
DE69528341T2 (de) Spritzenendstückkappe
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
BR9507091A (pt) Combinações insecticidamente ativas
ATA108995A (de) Differenzdruckakkumulator
ATA11894A (de) Stauförderbahn
SE9502578L (sv) Ändklokoppling
KR960003681U (ko) 호도까개
FI1696U1 (fi) Reklamsockel
ATE197372T1 (de) Vorteig
BR7400170U (pt) Mouráo
FIU940474U0 (fi) Bakugn-kaminugnkombination
BR7400053U (pt) T-compacto
BR7400242U (pt) Tele-comando
BR7400683U (pt) Odontoportátil
BR7400865U (pt) Multi-arremate
BR7400879U (pt) Boxboy
BR7401141U (pt) PortA-espoNja
BR7401146U (pt) Translixo
BR7400030U (pt) Numeralfa
ATA127394A (de) Holografischer neurochip
BR7401734U (pt) Termometro-caneta
ITMI940213A0 (it) Urinometro